Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2018.0270

News & Views

Pancreatic cancer genome analysis. New predictive approaches.

Evangelos Felekouras, MD, PhD.

Affiliation:1st Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Tel:+30213-206-1283
F: +30213-206-1779

E-mail: felek@med.uoa.gr

Abstract
Pancreatic adenocarcinoma is one of the most aggressive tumors with high mortality rates even in early-stage after surgical resection and adjuvant treatment.
Next-generation sequencing (NGS) in patient-derived samples has led into recent reports providing exciting data on pancreatic cancer driver genes druggable mutations. Whether the shifting from current progress to advances for the development of prognostic and predictive biomarkers with genome sequencing is discussed in this article.

(Citation: Gastric & Breast Cancer 2018; 13(1): 8-14)

Back

 

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 31 March 2018